> Agenda 2010

Program


09.00 am	Registration & poster exhibition opens The poster exhibition will be open all day

10.00 – 10.05 am	Welcome & opening remarks Dr Christian Stein, Ascenion GmbH

10.05 – 11.05 am	Presentation stream 1 Immune/Autoimmune & Oncology Chair: Dr Stèphane Mottola, FIST S.A. B1 Blockade of IL-3 is a promising novel strategy for arthritis therapy Prof. Matthias Mack, University of Regensburg B2 New isoform of the transcription factor RUNX1 (AML1) Prof. Stefan Gattenlöhner, University of Würzburg L2 CEACAM8: Promising therapeutic agent with pleitropic effect Dr Bernhard B. Singer, Charité – Universitätsmedizin Berlin F1 Tumor treatment Dr Michael Szardenings, Fraunhofer IZI N1 Circulating miRNAs as non-invasive markers for the prediction of tumor progression in prostate cancer, Jan Christoph Brase, German Cancer Research Center S1 New multi-target epigenetic anti-cancer drug Dr Hinrich Gronemeyer, CNRS

11.05 – 11.35 am	Poster session – Ask the experts

11.35 – 12.25 pm	Presentation stream 2 Drug Delivery & Drug Development & Cardiovascular Chair: Dr Jürgen Walkenhorst, PROvendis GmbH E1 Hepatitis B virus peptides as vehicles for specific delivery of compounds to the liver Prof. Stephan Urban, University Clinic Heidelberg U2 VLP based drug delivery Dr Heiko Manninga, Life Science Inkubator M1 Novel, highly selective inhibitors of CDK9 Dr Bert Klebl, Lead Discovery Center GmbH P1 Pellicious – Self-coating of lipid pellets by an extrusion / spheronisation process Prof. Joerg Breitkreutz, Heinrich-Heine-University of Duesseldorf P2 miR-126 Confers vascular protection – microRNA-126 for atherosclerosis protection and tissue repair Prof. Christian Weber, RWTH Aachen University

12.25 – 01.00 pm	Poster session – Ask the experts

12.25 – 01.30 pm	Lunch

01.30 – 02.45 pm	Spin-off Panel Moderator: Emmanuel Chantelot, Executive Director European Biopharmaceutical Enterprises (EBE) 1st round: DUALIS MedTech GmbH, iThera Medical GmbH, Innovative Health Diagnostics, Protagen AG, ethris GmbH 2nd round: Affectis Pharmaceuticals AG, SuppreMol GmbH, SpectraMab, Lead Discovery Center GmbH

02.45 – 03.45 pm	Presentation stream 3 Tools Chair: Kristin Sandereid, Birkeland Innovation AS A1 Novel hyperactive sleeping beauty transposase enables robust stable gene transfer in hard-to-transfect vertebrate cells both ex vivo and in vivo, Dr Zoltan Ivics, Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch K1 Artifi cial enzymes – polymer bound organocatalysts Dr Tor Erik Holt Kristensen, Univeristy of Oslo S2 Protein chips: Amphipols as universal adapters to immobilize membrane proteins onto solid supports, Dr Jean-Luc Popot W1 Improved protein production in mammalian cells Dr Anton Bauer A3 Iterative Chip-Based Cytometry (iCBC) Dr Christian Hennig, Hanover Medical School L3 Enabling technology: Direct assessment of cytotoxic T cell function Jonas Stanke, Corinna Hoffmann, Dr Andreas Kaufmann, ipal GmbH

03.45 – 04.10 pm	Poster session – Ask the experts

04.10 – 05.10 pm	Presentation stream 4 Neurological Disorders & Infection Chair: Dr. Joachim Vogt, Bayerische Patentallianz GmbH A2 New targets and related peptides for diagnostic use and treatment of Complex Regional Pain Syndrom Dr Pratibha Singh, Universitätsklinikum Gießen K2 New drug against brain edema Dr Katrine Rese Shadidi, Birkeland Innovation AS W2 New target for the treatment of bacterial infections, Dr Georg Casari, CEMM Research Center for Molecular Medicine of the Austrian Academy of Sciences I1 Novel pyrimidine derivatives for the treatment of picorna viral infections, Dr Atilla Coksezen, IP Bewertungs AG (IPB) L1 Modulation of production of retroviruses by APOBEC4 Daniela Marino, Paul Ehrlich Institut U1 Endotoxin bio-catalyzer Prof. Götz Nowak, Life science Inkubator

05.10 – 05.35 pm	Poster session – Ask the experts

05.35 pm	BioVaria Spin-off Award Ceremony

06.00 pm	Poster exhibition closes

Floorplan